Lebwohl, Mark G, Nehal N Mehta, Alice B Gottlieb, and Alan M Mendelsohn. “Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s42. Accessed July 5, 2022. https://www.jofskin.org/index.php/skin/article/view/991.